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1 AN ACT 
2 relating to the regulation of prescriptions for controlled 
3 substances, including certain procedures applicable to electronic 
4 prescriptions for Schedule II controlled substances. 
5 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: 
6 SECTION 1. Section 481. 061, Health and Safety Code, is 
7 amended by adding Subsection (d) to read as follows: 
8 (d) A person shall provide the department with the person's 
9 Federal Drug Enforcement Administration number not later than the 
10 45th day after the director issues a registration to the person 
11 under this subchapter. 
12 SECTION 2. Subsections (b), (c), (d-1), (e) through (h), 
13 (k), and (q), Health and Safety Code, are amended to read as 
14 follows: 
15 (b) Except in an emergency as defined by rule of the 
16 director ot as provided by Subsection (0) or Section 481.075(j) or 
17 (m), a person may not dispense or administer a controlled substance 
18 listed in Schedule II without ~ [~l written prescription of a 
19 practitioner on an official prescription form or without an 
20 electronic prescription that meets the requirements of and is 
21 completed by the practitioner in accordance with Section 481.075. 
22 In an emergency, a person may dispense or administer a controlled 
23 substance listed in Schedule II on the oral or telephonically 
24 communicated prescr iption of a practitioner. The person who 
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1 administer s or dispenses the substance shall: 
2 (1) if the person is a prescribing practitioner or a 
3 pharmacist, promptly comply with Subsection (c); or 
4 (2) if the person is not a prescribing practitioner or 
5 a pharmacist, promptly write the oral or telephonically 
6 communicated prescription and include in the written record of the 
7 prescription the name, address, [ae~az~meRt ze~istzatieR R~mSezi) 
, 
8 and Federal Drug Enforcement Administration number issued for 
9 prescr ibinq a controlled substance in this state of the prescr ibing 
10 practitioner, all information required to be provided by a 
11 practitioner under Section 481.075(e) (1), and all information 
12 required to be provided by a dispensing pharmacist under section 
13 481.075(e) (2). 
14 (c) Not later than the seventh day after the date a 
15 prescr ibing practitioner authorizes an emergency oral or 
16 telephonically communicated prescription, the prescribing 
17 practitioner shall cause a written or electronic prescription, 
18 completed in the manner required by Section 481. 075, to be 
19 delivered fiR ~ezseR ez mailea) to the dispensing pharmacist at the 
20 pharmacy where the prescription was dispensed. A written 
21 prescription may be delivered in person or by mail. The envelope of 
22 a prescription delivered by mail must be postmarked not later than 
23 the seventh day after the date the prescription was authorized. On 
24 receipt of a written [~) prescription, the dispensing pharmacy 
25 shall file the transcription of the telephonically communicated 
26 prescription and the pharmacy copy and shall send information to 
27 the director as required by Section 481.075. On receipt of an 
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1 electronic prescription, the pharmacist shall annotate the 
2 electronic presc.r iption record with the or iginal author ization and 
3 date of the emergency oral or telephonically communicated 
4 prescription. 
5 (d-l) Notwithstanding Subsection (d) , a prescribing 
6 practitioner may issue mUltiple prescriptions authorizing the 
7 patient to receive a total of up to a 90-day supply of a Schedule II 
8 controlled substance if: 
9 (1) each separate prescription is issued for a 
10 legitimate medical purpose by a prescribing practitioner acting in 
11 the usual course of professional practice; 
12 (2) the prescribing practitioner provides [\,·l'i'l;'I;eR] 
13 instructions on each prescription to be filled at a later date 
14 indicating the earliest date on which a pharmacy may fill each 
15 prescription; 
16 (3) the prescribing practitioner concludes that 
17 providing the patient with multiple prescriptions in this manner 
18 does not create an undue risk of diversion or abuse; and 
19 (4) the issuance of multiple prescriptions complies 
20 with other applicable state and federal laws. 
21 (e) The partial filling of a prescription for a controlled 
22 substance listed in Schedule II is permissible, if the pharmacist 
23 is unable to supply the full quantity called for in a written or 
24 electronic prescription or emergency oral prescription and the 
25 pharmacist makes a notation of the quantity supplied on the face of 
26 the written prescription, on the [~] written record of the 
27 emergency oral prescription, or in the electronic prescription 
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1 record. The remaining portion of the prescription may be filled 
2 within 72 hours of the first partial filling; however, if the 
3 remaining portion is not or cannot be filled within the 72-hour 
4 period, the pharmacist shall so notify the prescribing individual 
5 practitioner. No further quantity may be supplied beyond 72 hours 
6 without a new prescription. 
7 (f) A prescription for a Schedule II controlled substance 
8 [\1l'ieeeR] for a patient in a long-term care facility (LTCF) or for a 
9 patient with a medical diagnosis documenting a terminal illness may 
10 be filled in partial quantities to include individual dosage units. 
11 If there is any question about whether a patient may be classified 
12 as having a terminal illness, the pharmacist must contact the 
13 practitioner before partially filling the prescription. Both the 
14 pharmacist and the practitioner have a corresponding 
15 responsibility to assure that the controlled substance is for a 
16 terminally ill patient. The pharmacist must record the 
17 prescription on an official prescription form or in the electronic 
18 prescription record and must indicate on the official prescription 
19 form or in the electronic prescription record whether the patient 
20 is "terminally ill" or an "LTCF patient." A prescription that is 
21 partially filled and does not contain the notation "terminally ill" 
22 or "LTCF patient" is considered to have been filled in violation of 
23 this chapter. For each partial filling, the dispensing pharmacist 
24 shall record on the back of the official prescr iption form or in the 
25 electronic prescription record the date of the partial filling, the 
26 quantity dispensed, the remaining quantity authorized to be 
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Before any subsequent partial filling, the pharmacist 
determine that the additional partial filling is necessary. 
must 
The 
total quantity of Schedule II controlled substances dispensed in 
all partial fillings may not exceed the total quantity prescribed. 
Schedule II prescr iptions for patients in a long-term care facility 
or patients with a medical diagnosis documenting a terminal illness 
are valid for a period not to exceed 60 days following the issue 
date unless sooner terminated by discontinuance of the medication. 
(g) A person may not dispense a controlled substance in 
10 Schedule III or IV that is a prescription drug under the Federal 
11 Food, Drug, and Cosmetic Act (21 U.S.C. Section 301 et seq.) without 
12 a written, electronic, oral, or telephonically [S¥ elest¥sRieallyl 
13 communicated prescription of a practitioner defined by Section 
14 481.002(39) (A) or (D), except that the practitioner may dispense 
15 the substance directly to an ultimate user. A prescription for a 
16 controlled substance listed in Schedule III or IV may not be filled 
17 or refilled later than six months after the date on which the 
18 prescription is issued and may not be refilled more than five times, 
19 unless the prescription is renewed by the practitioner. A 
20 prescription under this subsection must comply with other 
21 applicable state and federal laws. 
22 (h) A pharmacist may dispense a controlled substance listed 
23 in Schedule III, IV, or V under a written, electronic, oral, or 
24 telephonically [s¥ elest¥sRieallyl communicated prescription 
25 issued by a practitioner defined by Section 481.002(39) (C) and only 
26 if the pharmacist determines that the prescr iption was issued for a 
27 valid medical purpose and in the course of professional practice. A 
o 
S.B. No. 594 
1 prescription issued under this subsection may not be filled or 
2 refilled later than six months after the date the prescription is 
3 issued and may not be refilled more than five times, unless the 
4 prescr iption is renewed by the practitioner. 
5 
6 
(k) A prescription for a controlled substance must show: 
(1) the quantity of the substance prescribed: 
7 (A) numerically, followed by the number written 
8 as a word, if the prescription is written; [erl 
9 (B) numerically, if the prescription is 
10 electronic; or 
11 ill if the prescription is communicated orally or 
12 telephonically, as transcribed by the receiving pharmacist; 
13 
14 
(2) the date of issue; 
(2-a) if the prescription is issued for a Schedule II 
15 controlled substance to be filled at a later date under Subsection 
16 (d-1), the earliest date on which a pharmacy may fill the 
17 prescription; 
18 (3) the name, address, and date of birth or age of the 
19 patient or, if the controlled substance is prescribed for an 
20 animal, the species of the animal and the name and address of its 
21 owner; 
22 (4) the name and strength of the controlled substance 
23 prescribed; 
24 (5) the directions for use of the controlled 
25 substance; 
26 (6) the intended use of the substance prescribed 
27 unless the practitioner determines the furnishing of this 
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1 information is not in the best interest of the patient; 
2 (7) the [le§isly ~YiR~eB sy s~am~eB] name, address, 
3 Federal Drug Enforcement Administration [ye§is~ya~isR] number, and 
4 telephone number of the practitioner at the practitioner's usual 
5 place of business, which must be legibly printed or stamped on a 
6 written prescription; and 
7 (8) if the prescription is handwritten, the signature 
8 of the prescribing practitioner [, aRB 
9 [(9) if ~Ae illessrisiR§ !JraetitieRer is lieeasea is 
11 (q) Each dispensing pharmacist shall send all information 
12 required by the director, including any information required to 
13 complete the Schedule III through V prescription forms, to the 
14 director by electronic transfer or another form approved by the 
15 director not later than the seventh [~l day after the date [las~ 
16 Bay sf ~Ae IIISR~A iR \TAiBA] the prescription is completely filled. 
17 SECTION 3. Subsections (a), (e), and (g) through (j), 
18 Section 481.075, Health and Safety Code, are amended to read as 
19 follows: 
20 (a) A practitioner who prescribes a controlled substance 
21 listed in Schedule II shall, except as provided by rule adopted 
22 under Section 481.0761, record the prescription on an official 
23 prescription form or in an electronic prescription that includes 
24 the information required by this section. 
25 (e) Each of f ic ial pre s c r ipt ion form .::o~r,--......::e~l:..::e:..::c::..:t::..:ro..:o::..:n:.:;l.:::.· c:::, 
26 prescription used to prescribe a Schedule II controlled substance 








(1) information provided 
practitioner, including: 
(A) the date the 
by the 
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prescribing 
is issued 
(B) the controlled substance prescribed; 
(e) the quantity of controlled substance 
7 prescribed, shown: 
8 (i) numerically.L followed by the number 
9 written as a word, if the prescription is written; or 
10 (ii) numerically, if the prescription is 
11 electronic; 
12 (D) the intended use of the controlled substance 
13 or the diagnosis for which it is prescr ibed and the instructions for 
14 use of the substance; 
15 
16 
(E) the practitioner's name, address, 
[ea~e~~~a~z~~~m~e~A~~&-~z~e~~~i~s~~~zha~~~1~'e~AB-~A~~~mM9~e~z~,l and Federal Drug Enforcement 











substance in this state; 
(F) the name, address, and date of birth or age of 
the person for whom the controlled substance is prescribed; and 
(G) if the prescription is issued to be filled at 
a later date under Section 481.074(d-1), the earliest date on which 
a pharmacy may fill the prescription; 
(2) information provided by the dispensing 
pharmacist, including the date the prescription is filled; and 
(3) for a written prescription, the signatures of the 
prescribing practitioner and the dispensing pharmacist or for an 
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1 electronic prescription, the prescribing practitioner's electronic 
2 signature or other secure method of validation authorized by 
3 federal law. 
4 (g) Except for an oral prescription prescribed under 
5 Section 481.074(b), ~he prescribing practitioner shall: 
6 (1) legibly fill in, or direct a designated agent to 
7 legibly fill in, on the official prescription form or in the 
8 electronic prescription, each item of information required to be 
9 provided by the prescribing practitioner under Subsection (e) (1), 
10 unless the practitioner determines that: 
11 
12 purpose, 
(A) under rule adopted by the director for this 
it is unnecessary for the practitioner or the 
13 practitioner's agent to provide the patient identification number; 
14 or 
15 (B) it is not in the best interest of the patient 
16 for the practitioner or practitioner's agent to provide information 
17 regarding the intended use of the controlled substance or the 
18 diagnosis for which it is prescribed; and 
19 (2) sign the official prescription form and give the 
20 form to the person author ized to receive the prescr iption or, in the 
21 case of an electronic prescription, electronically sign or validate 
22 the electronic prescription as authorized by federal law and 
23 transmit the prescription to the dispensing pharmacy. 
24 (h) In the case of an oral prescription prescribed under 
25 Section 481.074(b), the prescribing practitioner shall give the 
26 dispensing pharmacy the information needed to complete the official 
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(i) Each dispensing pharmacist shall: 
(1) fill in on the official prescription form or note 
3 in the electronic prescription record each item of information 
4 given orally to the dispensing pharmacy under Subsection (h) and[T] 
5 the date the prescr iption is filled, and..:.. 
6 (A) for a written prescription, fill in the 
7 dispensing pharmacist I s signature..i......Q!. 
8 (B) for an electronic prescription, 
9 appropriately record the identity of the dispensing pharmacist in 
10 the electronic prescription record; 
11 (2) retain with the records of the pharmacy for at 
12 least two year s: 
13 (A) the official prescription form or the 
14 electronic prescription record, as applicable; and 
15 (B) the name or other patient identification 
16 required by Section 481.074(m) or (n); and 
17 (3) send all information required by the director, 
18 including any information required to complete an official 
19 prescription form or electronic prescription record, to the 
20 director by electronic transfer or another form approved by the 
21 director not later than the seventh [~] day after the date [last 
22 Bay ef tAB BleatA ia ,.'!flieA] the prescription is completely filled. 
23 (j) A medication order written for a patient who is admitted 
24 to a hospital at the time the medication order is written and filled 
25 is not required to be on an official prescription [a] form or in an 
26 electronic prescription record that meets the requirements of this 
27 section. 
o 
S.B. No. 594 
1 SECTION 4. Subsections (a) and (i), Section 481.076, Health 
2 and Safety Code, are amended to read as follows: 
3 (a) The director may not permit any person to have access to 
4 information submitted to the director under Section 481.074(q) or 
5 481. 075 except: 
6 (1) an investigator for the Texas Medical Board, the 
7 Texas State Board of Podiatric Medical Examiners, the State Board 
8 of Dental Examiners, the State Board of Veterinary Medical 
9 Examiners, the Texas Board of Nursing, or the Texas State Board of 
10 Pharmacy; 
11 (2) an authorized officer or member of the department 
12 engaged in the administration, investigation, or enforcement of 
13 this chapter or another law governing illicit drugs in this state or 
14 another state; or 
15 (3) if the director finds that proper need has been 
16 shown to the director: 
17 (A) a law enforcement or prosecutorial official 
18 engaged in the administration, investigation, or enforcement of 
19 this chapter or another law governing illicit drugs in this state or 
20 another state; 
21 (B) a pharmacist or practitioner who is a 
22 physician, dentist, veterinarian, podiatrist, or advanced practice 
23 nurse or physician assistant described by Section 481.002(39)(0) 
24 and is inquir ing about a recent Schedule II, III, IV, or V 
25 prescription history of a particular patient of the practitioner; 
26 or 
27 (C) a pharmacist or practitioner who is inquiring 
11 
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1 about the person's own dispensing or prescribing activity. 
2 (i) Information submitted to the director under Section 
3 481.074(g) or 481.075 is confidential and remains confidential 
4 regardless of whether the director permits access to the 
5 information under this section. 
6 SECTION 5. Subsection (d), Section 481.0761, Health and 
7 Safety Code, is amended to read as follows: 
8 (d) The director by rule shall authorize a practitioner to 
9 determine whether it is necessary to obtain a particular patient 
10 identification number and to provide that number on the official 
11 prescription form or in the electronic prescription record. 
12 SECTION 6. Section 552.118, Government Code, is amended to 
13 read as follows: 
14 Sec. 552.118. EXCEPTION: OFFICIAL PRESCRIPTION PROGRAM 
15 INFORMATION [~l. Information is excepted from the requirements 
16 of Section 552.021 if it is: 
17 (1) information on or derived from an official 
18 prescription form or electronic prescription record filed with the 
19 director of the Department of Public Safety under Section 481.075, 
20 Health and Safety Code; or 
21 (2) other information collected under Section 481.075 
22 of that code. 
23 SECTION 7. Subsection (c), Section 157.059, occupations 
24 Code, is amended to read as follows: 
25 
26 
(c) The physician may not delegatel. 
ill the use of a prescription sticker or the use or 
27 issuance of an official prescription form; or 
12 
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1 (2) the authority to issue an electronic prescription 
2 under Section 481.075, Health and Safety Code. 
3 SECTION 8. Notwithstanding Section 481.061, Health and 
4 Safety Code, as amended by this Act, a person who holds a valid 
5 registration under Subchapter C, Chapter 481, Health and Safety 
6 Code, on the effective date of this Act is not required to submit 
7 the person's Federal Drug Enforcement Administration number to the 
8 Department of Public Safety of the State of Texas before October 15, 
9 201l. 
10 SECTION 9. The change in law made by this Act applies only 
11 to the issuance of a prescription on or after the effective date of 
12 this Act. The issuance of a prescr iption before the effective date 
13 of this Act is covered by the law in effect when the prescription 
14 was issued, and the former law is continued in effect for that 
15 purpose. 
16 SECTION 10. This Act takes effect September 1, 2011. 
13 
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President of the Senate 
I hereby certify that S.B. No. the Senate on 
March 24, 2011, by the following vote: Yeas 31, Nays 0; and that 
the Senate concurred in House amendment on May 27, 2011, by the 
following vote: Yeas 31, Nays 0 _________________ _ 
I hereby certify that S.B. No. 594 passed the House, with 
amendment, on May 23, 2011, by the following vote: Yeas 145, 
Nays 0, two present not voting .... __________________ _ 
Approved: 
J7J1v'l/ 
FILED IN THE OFFICE OF THE 
Sf):,RI;TAI1IYOF STATE 
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